A detailed history of New Edge Advisors, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 57 shares of MRVI stock, worth $313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57
Previous 57 -0.0%
Holding current value
$313
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$6.87 - $11.34 $2,486 - $4,105
-362 Reduced 86.4%
57 $0
Q1 2024

May 14, 2024

SELL
$5.11 - $8.76 $965 - $1,655
-189 Reduced 31.09%
419 $3,000
Q4 2023

Feb 13, 2024

BUY
$4.7 - $9.87 $2,641 - $5,546
562 Added 1221.74%
608 $3,000
Q3 2023

Nov 14, 2023

SELL
$9.14 - $12.85 $1,069 - $1,503
-117 Reduced 71.78%
46 $0
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $1,414 - $1,755
117 Added 254.35%
163 $2,000
Q1 2023

May 12, 2023

SELL
$12.99 - $16.48 $480 - $609
-37 Reduced 44.58%
46 $0
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $1,037 - $2,056
83 New
83 $1,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.